From Casetext: Smarter Legal Research

Wolfgruber v. Upjohn Company

Court of Appeals of the State of New York
Dec 18, 1980
52 N.Y.2d 768 (N.Y. 1980)

Opinion

Argued November 20, 1980

Decided December 18, 1980

Appeal from the Appellate Division of the Supreme Court in the Fourth Judicial Department, MARSHALL E. LIVINGSTON, J.

David A. Shults for appellant.

Andrea Lynch for respondent.


Order affirmed, with costs, for reasons stated in the opinion by Mr. Justice RICHARD J. CARDAMONE at the Appellate Division ( 72 A.D.2d 59).

Concur: Chief Judge COOKE and Judges JASEN, GABRIELLI, JONES and WACHTLER. Judge MEYER dissents and votes to reverse in an opinion in which Judge FUCHSBERG concurs.


I would reverse and reinstate the order of Special Term which denied summary judgment to plaintiff based in part on the fact that "plaintiff has not yet deposed the defendant."

Plaintiff, a physician, seeks to recover from defendant, drug manufacturer, for failure adequately to warn concerning the effects of the drug Cleocin. The Appellate Division reversing, granted summary judgment to defendant and held the warning contained in the package insert and in the Physician's Desk Reference adequate as a matter of law.

Plaintiff's infection developed in 1974 following administration of Cleocin to himself. Whether his doing so in the face of the warning printed in the insert and the desk reference and in view of his medical knowledge constituted contributory negligence or assumption of the risk presents a jury question and furnishes no basis for summary judgment. Nor should plaintiff have been nonsuited on the adequacy of warning issue. Doing so deprived him of his right to explore via pretrial discovery the facts known to defendant in 1974 as a basis for determining adequacy of the warning.

How fruitful such discovery can be is, quite fortuitously, available in the record of a nearly identical case, Werner v Upjohn Co. ( 628 F.2d 848). Comparison of defendant's 1974 warning in the record of the present case with that in its 1974 "Dear Doctor" letter for the same drug set forth in the opinion in Werner shows the latter to be more detailed. Moreover, the history of the drug recounted in that opinion shows that disclosure may well provide plaintiff with evidence sufficient to take to the jury the question of adequacy of the warning relied upon by defendant in this case.

Plaintiff should not have been no-caused without an opportunity to obtain defendant's records relating to its knowledge about and experience with the drug (CPLR 3212, subd [f]).

Order affirmed, etc.


Summaries of

Wolfgruber v. Upjohn Company

Court of Appeals of the State of New York
Dec 18, 1980
52 N.Y.2d 768 (N.Y. 1980)
Case details for

Wolfgruber v. Upjohn Company

Case Details

Full title:PAUL WOLFGRUBER, Appellant, v. UPJOHN COMPANY, Respondent

Court:Court of Appeals of the State of New York

Date published: Dec 18, 1980

Citations

52 N.Y.2d 768 (N.Y. 1980)
436 N.Y.S.2d 614
417 N.E.2d 1002

Citing Cases

Schumacher v. Shear Co.

Indeed, causes of action for failure to warn are so similar, whether sounding in negligence or strict…

McFadden v. Haritatos

On examination before trial, defendant physician acknowledged he was familiar with the side effects of…